Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

515 public trials 167 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Recruiting

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

NCT07220083

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +7 more
Locations
  • Alabama Kidney Research Alabaster, Alabama, United States
  • Apogee Clinical Research Huntsville, Alabama, United States
  • Southwest Kidney Institute Surprise, Arizona, United States
  • West Coast Kidney Institute Fremont, California, United States
View all 309 locations
View Trial Details
Recruiting

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

NCT06989359

Conditions
Autoimmune Diseases, C3G, Complement-mediated Kidney Disease, +13 more
Locations
  • ADARx Clinical Site Doral, Florida, United States
  • ADARx Clinical Site Miami, Florida, United States
  • ADARx Clinical Site Pembroke Pines, Florida, United States
  • ADARx Clinical Site Iowa City, Iowa, United States
View all 38 locations
View Trial Details
Recruiting

Chinese Adults With Kidney Disease

NCT07522099

Conditions
Autoimmune Diseases, Complement 3 Glomerulopathy (C3G), Female Urogenital Diseases, +12 more
Locations
  • ADARx Clinical Site Shenzhen, Guangdong, China
  • ADARx Clinical Site Guiyang, Guizhou, China
  • ADARx Clinical Site Zhengzhou, Henan, China
  • ADARx Clinical Site Baotou, Inner Mongolia, China
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

NCT05039619

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Loma Linda University health Loma Linda, California, United States
  • UCSF Benioff Childrens Hospital San Francisco, California, United States
  • Children's Hospital Colorado, Anchutz Medical Campus Aurora, Colorado, United States
  • Emory Children's Center Atlanta, Georgia, United States
View all 43 locations
View Trial Details
Recruiting

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

NCT06935357

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Applied Research Center of Arkansas Little Rock, Arkansas, United States
  • Kidney & Hypertension Center - Apple Valley Apple Valley, California, United States
  • Scripps Green Hospital Carlsbad, California, United States
  • National Institute of clinical Research Administration Office Garden Grove, California, United States
View all 260 locations
View Trial Details
Recruiting

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

NCT07570862

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations
  • Wallace Rheumatic Studies Center Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Miami Dermatology and Laser Research Miami, Florida, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 16 locations
View Trial Details

Related conditions